The New York Entrepreneur

Prescription-drug middlemen face more pressure from FTC in new report

Read Time:6 Second

The Federal Trade Commission on Tuesday ramped up the pressure on prescription-drug middlemen who influence the accessibility and affordability of medications.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Largest U.S. banks may save billions on Fed surcharge: report
Next post Why Schwab’s stock is getting new respect from Wall Street analysts